Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
NiQuitin Pre-Quit Clear 21mg patches
0410020B0BDARAR
|
NiQuitin | Nicotine | Central Nervous System | 27 |
|
Oxylan 60mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFAMAQ
|
Oxylan | Oxycodone hydrochloride | Central Nervous System | 27 |
|
Prefibin 0.4mg sublingual tablets
0410030A0BCAAAC
|
Prefibin | Buprenorphine hydrochloride | Central Nervous System | 27 |
|
Quetiapine 200mg/5ml oral suspension
0402010ABAAARAR
|
Quetiapine | Quetiapine | Central Nervous System | 27 |
|
Sultiame 50mg tablets
0408010Y0AAAAAA
|
Sultiame | Sultiame | Central Nervous System | 27 |
|
Actiq 800microgram loz with integral oromucosal applicator
0407020A0BCADAL
|
Actiq | Fentanyl | Central Nervous System | 26 |
|
Briviact 10mg tablets
0408010ALBBAAAA
|
Briviact | Brivaracetam | Central Nervous System | 26 |
|
Desitrend 500mg/5ml concentrate for inf ampoules
0408010A0BDAEAN
|
Desitrend | Levetiracetam | Central Nervous System | 26 |
|
Emylif 50mg orodispersible films
0409030R0BDAAAE
|
Emylif | Riluzole | Central Nervous System | 26 |
|
Epanutin 100mg capsules
0408010Q0BBAEAA
|
Epanutin (Capsule) | Phenytoin sodium | Central Nervous System | 26 |
|
Fentanyl 1.6mg lozenges
0407020A0AAAPAP
|
Fentanyl | Fentanyl | Central Nervous System | 26 |
|
Fentanyl 600microgram sublingual tablets sugar free
0407020A0AABABA
|
Fentanyl | Fentanyl | Central Nervous System | 26 |
|
MigraKind 50mg tablets
0407041T0BGAAAF
|
MigraKind | Sumatriptan succinate | Central Nervous System | 26 |
|
Optimax 500mg capsules (Special Order)
0403040S0BBADAI
|
Optimax | Tryptophan | Central Nervous System | 26 |
|
Amobarbital sodium 60mg capsules
0401030E0AAAAAA
|
Amobarbital sodium | Amobarbital sodium | Central Nervous System | 25 |
|
Aripiprazole 1mg tablets
0402010ADAAALAL
|
Aripiprazole | Aripiprazole | Central Nervous System | 25 |
|
Botox 200unit powder for solution for injection vials
0409030B0BCACAG
|
Botox | Botulinum toxin type A | Central Nervous System | 25 |
|
Invega 6mg modified-release tablets
0402010AEBBABAB
|
Invega | Paliperidone | Central Nervous System | 25 |
|
Levetiracetam 1.5g gran for soln sachets sugar free
0408010A0AAATAT
|
Levetiracetam | Levetiracetam | Central Nervous System | 25 |
|
Pregabalin 150mg/5ml oral liquid
0408010AEAAAJAJ
|
Pregabalin | Pregabalin | Central Nervous System | 25 |
|
Sodium valproate 400mg/4ml solution for injection ampoules
0408010W0AABZBZ
|
Sodium valproate | Sodium valproate | Central Nervous System | 25 |
|
Tradorec XL 300mg tablets
040702040BIACAM
|
Tradorec | Tramadol hydrochloride | Central Nervous System | 25 |
|
Zofran Melt 8mg oral lyophilisates
0406000S0BBAJAJ
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 25 |
|
Axalid 225mg capsules
0408010AEBFAGAI
|
Axalid | Pregabalin | Central Nervous System | 24 |
|
Benzatropine 2mg tablets
0409020E0AAABAB
|
Benzatropine mesilate | Benzatropine mesilate | Central Nervous System | 24 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.